JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME Activity
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chung, J.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, J.-K.
Journal of Nuclear Medicine Vol. 43 No. 9 1188-1200
© 2002 by Society of Nuclear Medicine


Continuing Education

Sodium Iodide Symporter: Its Role in Nuclear Medicine*

June-Key Chung, MD, PhD1

1 Department of Nuclear Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

Thyroid iodide uptake is basic to the clinical applications of radioiodine. Iodide uptake occurs across the membrane of the thyroid follicular cells through an active transporter process mediated by the sodium iodide symporter (NIS). The recent cloning of the NIS gene enabled the better characterization of the molecular mechanisms underlying iodide transport, thus opening the way to the clarification and expansion of its role in nuclear medicine. In papillary and follicular carcinoma, NIS immunostaining was positive in only a few tumor cells, and no NIS protein expression was detected in anaplastic carcinomas. Decreased NIS expression levels account for the reduced iodide uptake in thyroid carcinomas. Thus, by targeting NIS expression in cancer cells, we could enable these cells to concentrate iodide from plasma and in so doing offer the possibility of radioiodine therapy. Several investigators have shown that gene transfer of NIS into a variety of cell types confers increased radioiodine uptake by up to several hundredfold that of controls in nonthyroid cancers as well as in thyroid cancer. In addition, my group proposes that NIS may serve as an alternative imaging reporter gene in addition to the HSVtk and dopaminergic receptor genes. The NIS has the potential to expand the role of nuclear medicine in the future, just as it has served as the base for the development of nuclear medicine in the past.

Key Words: sodium iodide symporter • thyroid carcinoma • gene therapy • reporter gene




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
Y. H. Jeon, Y. Choi, C. W. Kim, Y.-H. Kim, H. Youn, J. Lee, and J.-K. Chung
Human Sodium/Iodide Symporter-Mediated Radioiodine Gene Therapy Enhances the Killing Activities of CTLs in a Mouse Tumor Model
Mol. Cancer Ther., January 1, 2010; 9(1): 126 - 133.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. J. Chisholm, G. Vassaux, P. Martin-Duque, R. Chevre, O. Lambert, B. Pitard, A. Merron, M. Weeks, J. Burnet, I. Peerlinck, et al.
Cancer-Specific Transgene Expression Mediated by Systemic Injection of Nanoparticles
Cancer Res., March 15, 2009; 69(6): 2655 - 2662.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S.-Y. Park, W. Kwak, N. Tapha, M.-Y. Jung, J.-O. Nam, I.-S. So, S.-Y. Kim, J. Yoo, J. Lee, and I.-S. Kim
Combination Therapy and Noninvasive Imaging with a Dual Therapeutic Vector Expressing MDR1 Short Hairpin RNA and a Sodium Iodide Symporter
J. Nucl. Med., September 1, 2008; 49(9): 1480 - 1488.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. J. Yeom, J.-K. Chung, J. H. Kang, Y. H. Jeon, K. I. Kim, Y. N. Jin, Y. M. Lee, J. M. Jeong, and D. S. Lee
Visualization of Hypoxia-Inducible Factor-1 Transcriptional Activation in C6 Glioma Using Luciferase and Sodium Iodide Symporter Genes
J. Nucl. Med., September 1, 2008; 49(9): 1489 - 1497.
[Abstract] [Full Text] [PDF]


Home page
Exp Biol MedHome page
Z. Lee, J. E. Dennis, and S. L. Gerson
Imaging Stem Cell Implant for Cellular-Based Therapies
Exp Biol Med, August 1, 2008; 233(8): 930 - 940.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. H. Jeon, Y. Choi, S. O. Yoon, C. W. Kim, and J.-K. Chung
Synergistic tumoricidal effect of combined hMUC1 vaccination and hNIS radioiodine gene therapy
Mol. Cancer Ther., July 1, 2008; 7(7): 2252 - 2260.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. H. Kang and J.-K. Chung
Molecular-Genetic Imaging Based on Reporter Gene Expression
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 164S - 179S.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. Dayem, C. Basquin, V. Navarro, P. Carrier, R. Marsault, P. Chang, S. Huc, E. Darrouzet, S. Lindenthal, and T. Pourcher
Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization
J. Endocrinol., April 1, 2008; 197(1): 95 - 109.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Goel, S. K. Carlson, K. L. Classic, S. Greiner, S. Naik, A. T. Power, J. C. Bell, and S. J. Russell
Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV({Delta}51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene
Blood, October 1, 2007; 110(7): 2342 - 2350.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. I. Kim, J. H. Kang, J.-K. Chung, Y. J. Lee, J. M. Jeong, D. S. Lee, and M. C. Lee
Doxorubicin Enhances the Expression of Transgene Under Control of the CMV Promoter in Anaplastic Thyroid Carcinoma Cells
J. Nucl. Med., September 1, 2007; 48(9): 1553 - 1561.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. W. Hwang, J. H. Kang, Y. S. Chang, J. M. Jeong, J.-K. Chung, M. C. Lee, S. Kim, and D. S. Lee
Development of a Dual Membrane Protein Reporter System Using Sodium Iodide Symporter and Mutant Dopamine D2 Receptor Transgenes
J. Nucl. Med., April 1, 2007; 48(4): 588 - 595.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Zhou, P. D. Acton, and V. A. Ferrari
Imaging Stem Cells Implanted in Infarcted Myocardium
J. Am. Coll. Cardiol., November 21, 2006; 48(10): 2094 - 2106.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K.-H. Lee, J.-S. Bae, S.-C. Lee, J.-Y. Paik, T. Matsui, K.-H. Jung, B.-H. Ko, and B.-T. Kim
Evidence that Myocardial Na/I Symporter Gene Imaging Does Not Perturb Cardiac Function
J. Nucl. Med., November 1, 2006; 47(11): 1851 - 1857.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Elisei, A. Vivaldi, R. Ciampi, P. Faviana, F. Basolo, F. Santini, C. Traino, F. Pacini, and A. Pinchera
Treatment with Drugs Able to Reduce Iodine Efflux Significantly Increases the Intracellular Retention Time in Thyroid Cancer Cells Stably Transfected with Sodium Iodide Symporter Complementary Deoxyribonucleic Acid
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2389 - 2395.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W.-P. Deng, C.-C. Wu, C.-C. Lee, W. K. Yang, H.-E. Wang, R.-S. Liu, H.-J. Wei, J. G. Gelovani, J.-J. Hwang, D.-M. Yang, et al.
Serial In Vivo Imaging of the Lung Metastases Model and Gene Therapy Using HSV1-tk and Ganciclovir
J. Nucl. Med., May 1, 2006; 47(5): 877 - 884.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Z. Zhang, Y.-Y. Liu, and S. M. Jhiang
Cell Surface Targeting Accounts for the Difference in Iodide Uptake Activity between Human Na+/I- Symporter and Rat Na+/I- Symporter
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6131 - 6140.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Puppin, F. D'Aurizio, A. V. D'Elia, L. Cesaratto, G. Tell, D. Russo, S. Filetti, E. Ferretti, E. Tosi, T. Mattei, et al.
Effects of Histone Acetylation on Sodium Iodide Symporter Promoter and Expression of Thyroid-Specific Transcription Factors
Endocrinology, September 1, 2005; 146(9): 3967 - 3974.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K.-H. Lee, H.-K. Kim, J.-Y. Paik, T. Matsui, Y. S. Choe, Y. Choi, and B.-T. Kim
Accuracy of Myocardial Sodium/Iodide Symporter Gene Expression Imaging with Radioiodide: Evaluation with a Dual-Gene Adenovirus Vector
J. Nucl. Med., April 1, 2005; 46(4): 652 - 657.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. H. Kang, D. S. Lee, J. C. Paeng, J. S. Lee, Y. H. Kim, Y. J. Lee, D. W. Hwang, J. M. Jeong, S. M. Lim, J.-K. Chung, et al.
Development of a Sodium/Iodide Symporter (NIS)-Transgenic Mouse for Imaging of Cardiomyocyte-Specific Reporter Gene Expression
J. Nucl. Med., March 1, 2005; 46(3): 479 - 483.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. C F Ferreira, L. P Lima, R. L Araujo, G. Muller, R. P Rocha, D. Rosenthal, and D. P Carvalho
Rapid regulation of thyroid sodium-iodide symporter activity by thyrotrophin and iodine
J. Endocrinol., January 1, 2005; 184(1): 69 - 76.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. I. Kim, J.-K. Chung, J. H. Kang, Y. J. Lee, J. H. Shin, H. J. Oh, J. M. Jeong, D. S. Lee, and M. C. Lee
Visualization of Endogenous p53-Mediated Transcription In vivo Using Sodium Iodide Symporter
Clin. Cancer Res., January 1, 2005; 11(1): 123 - 128.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. J. Buchsbaum, T. R. Chaudhuri, and K. R. Zinn
Radiotargeted Gene Therapy
J. Nucl. Med., January 1, 2005; 46(1_suppl): 179S - 186S.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Miyagawa, M. Beyer, B. Wagner, M. Anton, C. Spitzweg, B. Gansbacher, M. Schwaiger, and F. M. Bengel
Cardiac reporter gene imaging using the human sodium/iodide symporter gene
Cardiovasc Res, January 1, 2005; 65(1): 195 - 202.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. H. Shin, J.-K. Chung, J. H. Kang, Y. J. Lee, K. I. Kim, Y. So, J. M. Jeong, D. S. Lee, and M. C. Lee
Noninvasive Imaging for Monitoring of Viable Cancer Cells Using a Dual-Imaging Reporter Gene
J. Nucl. Med., December 1, 2004; 45(12): 2109 - 2115.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. H. Kang, J.-K. Chung, Y. J. Lee, J. H. Shin, J. M. Jeong, D. S. Lee, and M. C. Lee
Establishment of a Human Hepatocellular Carcinoma Cell Line Highly Expressing Sodium Iodide Symporter for Radionuclide Gene Therapy
J. Nucl. Med., September 1, 2004; 45(9): 1571 - 1576.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
X. Lin, A. H. Fischer, K.-y. Ryu, J.-y. Cho, T. J. Sferra, R. T. Kloos, E. L. Mazzaferri, and S. M. Jhiang
Application of the Cre/loxP System to Enhance Thyroid-Targeted Expression of Sodium/Iodide Symporter
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2344 - 2350.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
U. Haberkorn, P. Beuter, W. Kubler, H. Eskerski, M. Eisenhut, R. Kinscherf, S. Zitzmann, L. G. Strauss, A. Dimitrakopoulou-Strauss, and A. Altmann
Iodide Kinetics and Dosimetry In Vivo After Transfer of the Human Sodium Iodide Symporter Gene in Rat Thyroid Carcinoma Cells
J. Nucl. Med., May 1, 2004; 45(5): 827 - 833.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. De la Vieja, C. S. Ginter, and N. Carrasco
The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number
J. Cell Sci., February 15, 2004; 117(5): 677 - 687.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. Carlin, G. Akabani, and M. R. Zalutsky
In Vitro Cytotoxicity of 211At-Astatide and 131I-Iodide to Glioma Tumor Cells Expressing the Sodium/Iodide Symporter
J. Nucl. Med., November 1, 2003; 44(11): 1827 - 1838.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E. Dadachova and L. S. Zuckier
Overlooked Contributions on Sodium Iodide Symporter
J. Nucl. Med., October 1, 2003; 44(10): 1707 - 1707.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.